发明名称 |
FC101 as a method of treatment for cancer |
摘要 |
The present invention provides a treatment for angiogenic diseases, including solid tumors. The treatment consists of administering therapeutically active dosages of FC101, resulting in a reduction in endothelial cell proliferation and inhibition of new blood vessel formation. FC101 can also be used as a lead compound to develop other pharmacologically-active compounds, by adding or substituting different functional groups for those already present on the FC101 molecule.
|
申请公布号 |
US2003083370(A1) |
申请公布日期 |
2003.05.01 |
申请号 |
US20020211466 |
申请日期 |
2002.08.02 |
申请人 |
WUTHIER ROY E.;NIE DAOTAI |
发明人 |
WUTHIER ROY E.;NIE DAOTAI |
分类号 |
A61K31/335;A61K31/35;A61K31/352;A61K31/353;A61K31/366;A61K36/06;A61P35/00;(IPC1-7):A61K31/366 |
主分类号 |
A61K31/335 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|